News
Unless you’ve been living in Bilbo Baggins’ Hobbit-burrow, you surely know that GLP1s (Glucagon-like peptide-1) and their “cousin,” GIP (glucose-dependent insulinotropic polypeptide), e.g., Ozempic, ...
About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...
Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a Maryland man who developed non-arteritic anterior ischemic optic neuropathy ...
More information: Alan Y. Hsu et al, Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2025.0349 ...
Considering taking supplements to treat ischemic optic neuropathy? Below is a list of common natural remedies used to treat or reduce the symptoms of ischemic optic neuropathy. Follow the links to ...
A man is suing the manufacturers of Ozempic, alleging the diabetes drug caused him to go blind. The medication, containing ...
Nonarteritic anterior ischemic optic neuropathy—known as NAION—can cause sudden blindness when blood flow to the optic nerve is blocked. It’s not clear what causes the condition, although ...
Hosted on MSN1mon
Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in DiabetesTUESDAY, April 8, 2025 (HealthDay News) -- For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results